Award-winning Agilex Biolabs, the Asia-Pacific region’s leading bioanalytical laboratory for clinical trials, based in Australia, has developed the world’s most accurate cannabinoid assay.
Gathering together the key clinical service providers for a trial can be a daunting process – especially if you are going off-shore to reactivate trials or start new trials to make up for COVID delays.
However, Australia offers a refreshingly streamlined process because of its group of proven top-tier providers that regularly work together so are fully engaged and in sync with processes and each other’s requirements and capabilities. This makes setting up trials in Australia a smooth, professional, and rapid process for biotechs. This webinar looks at how moving trials to Australia could be much easier than you think.
However, Australia offers a refreshingly streamlined process because of its group of proven top-tier providers that regularly work together so are fully engaged and in sync with processes and each other’s requirements and capabilities. This makes setting up trials in Australia a smooth, professional, and rapid process for biotechs. This webinar looks at how moving trials to Australia could be much easier than you think.
All right. Hi everybody. I’m Arsalan Arif, the publisher of Endpoints News and I’m pleased to be your moderator today. Today’s webinar is sponsored by Agilex Biolabs in Australia and our topic is the Australian Advantage, de-risk your early phase trials. I’m joined by Dr Kurt Sales today with Agilex Biolabs. He’s got an approximately 20 minute presentation and we’re going to follow it up with a quick Q&A. And now I give you Dr Kurt Sales.
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, and Endpoints News launched a new webinar “How Easy is it to Move Your Trials to Australia” at BIO Asia-Taiwan 2020.
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for clinical trials, encouraged biotechs to consider Australia for their clinical trials during a presentation at BIO Digital 2020.
Agilex Biolabs, Australia’s largest specialist bioanalytical laboratory for biotech clinical trials, is presenting the Australian Advantage including the world’s most attractive rebate on clinical trials costs, at BIO Korea 2020.
The reality is, Australia has fantastic key opinion leaders, some great principal investigators that have been running clinical trials for decades. The CROs, RFA with FDA and EMA requirements. And in fact, our whole Australian service provision industry sets itself to that standard because ultimately that is the client base that Australia is servicing. Most CROs in Australia and service providers will be able to talk about situations where their data has been presented to the FDA or EMA with success.
https://youtu.be/WNdPGkdr9FA...
Video https://www.youtube.com/watch?v=sCUT8qtlRX4&feature=youtu.be...
Award-winning Australian bioanalytical laboratory Agilex Biolabs announced today it has appointed US-based Dr Caroline Popper, MBBS, MPH as Board Chair as part of its APAC clinical trials bioanalytics growth plans.
